...
机译:最大化ER-α降解最大化在三种氧化乳腺癌模型中的活性:GDC-0927的鉴定
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
Department of Chemistry Department of Biology and Department of Drug Safety and Disposition Seragon Pharmaceuticals;
antagonist; breast cancer; chromene; Estrogen receptor; estrogen receptor degrader; GDC-0927; SERD; SRN-927; tamoxifen-resistant;
机译:最大化ER-α降解最大化在三种氧化乳腺癌模型中的活性:GDC-0927的鉴定
机译:GDC-0810(ARN-810)的鉴定,这是一种口服可生物利用的选择性雌激素受体降解剂(SERD),可在抗他莫昔芬的乳腺癌异种移植物中显示出强劲的活性。
机译:Bazedoxifene在他莫昔芬耐药性乳腺癌动物模型中显示抗雌激素活性:对晚期疾病的治疗意义
机译:基于期望最大化的逻辑回归进行乳腺癌分类
机译:eIF4E在抗他莫昔芬的ER +乳腺癌中进行翻译重编程。
机译:最大化ER-α降解最大化他莫昔芬抗性乳腺癌模型中的活性:鉴定GDC-0927的
机译:模型驱动的剂量方案鉴定,使一氧化氮的抗菌活性最大化
机译:ERalpha-ERRalpha异二聚体在他莫昔芬抗性乳腺癌中的作用。